Nathan Rice
Stock Analyst at Piper Sandler
(3.13)
# 1,146
Out of 5,141 analysts
61
Total ratings
52.63%
Success rate
12.22%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $142.97 | +4.92% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $43.84 | +9.49% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $45.33 | -7.35% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $33.13 | +5.64% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $76.69 | -3.51% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $161.37 | -47.95% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $190.02 | +3.67% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $24.98 | -63.97% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $635.66 | -31.57% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $280.31 | -16.88% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $43.24 | +91.95% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $20.57 | -27.08% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $142.97
Upside: +4.92%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $43.84
Upside: +9.49%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $45.33
Upside: -7.35%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $33.13
Upside: +5.64%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $76.69
Upside: -3.51%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $161.37
Upside: -47.95%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $190.02
Upside: +3.67%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $24.98
Upside: -63.97%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $635.66
Upside: -31.57%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $280.31
Upside: -16.88%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $43.24
Upside: +91.95%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $20.57
Upside: -27.08%